← SynDRA
SB 239063
SynDRA canonical compound SYN1955708 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MAPK11 | MAPK14 | PTGS2 | TNF |
| Mechanism of action | p38 MAPK inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- SB-239063
- SB239063
- UNII-HII3DC8CPI
- HII3DC8CPI
- CHEMBL97162
- trans-1-(4-hydroxycyclohexyl)-4-(4-fluorophenyl)-5-(2-methoxypyridimidin-4-yl)imidazole
- CHEBI:90681
- TRANS-1-(4-HYDROXYCYCLOHEXYL)-4-(4-FLUOROPHENYL)-5-(2-METHOXYPYRIMIDIN-4-YL) IMIDAZOLE
- trans-4-[4-(4-Fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]cyclohexanol
- 4-[4-(4-fluorophenyl)-5-(2-methoxypyrimidin-4-yl)imidazol-1-yl]cyclohexan-1-ol
Look up SB 239063 in the interactive SynDRA portal →